Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Ziegelmann

Urology Rochester, MN Medical Doctor

NPI 1386080018 CMS profile 516625

200 1St St Sw, Rochester, MN 55905

Open in the dashboard

General payments

$9,274

68 records reported · program years 2019–2025

Research payments

$1,250

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$45,663 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Matthew Ziegelmann of Rochester, MN is reported in the CMS Open Payments database as having received $9,274 across 68 general payments and $1,250 in research payments paid to them. Separately, studies naming them as principal investigator received $45,663 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 81st percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $507 5
2024 General $618 20
2023 General $635 8
2022 General $5,122 11
2022 Research $1,250 1
2021 General $1,113 8
2020 General $169 2
2019 General $1,110 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Ziegelmann
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Matthew Ziegelmann were reported at $507. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Matthew Ziegelmann Urology median Middle half National median
2019 $1,110 $480 $147–$1,201 $163
2020 $169 $246 $87–$645 $114
2021 $1,113 $358 $111–$1,000 $132
2022 $5,122 $476 $143–$1,263 $149
2023 $635 $560 $168–$1,461 $160
2024 $618 $563 $170–$1,464 $164
2025 $507 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Endo Pharmaceuticals Inc. $4,596 3 payments
  2. Coloplast Corp $2,754 41 payments
  3. Boston Scientific Corporation $1,818 22 payments
  4. Axonics Modulation Technologies, Inc. $71 1 payment
  5. AstraZeneca Pharmaceuticals LP $35 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $5,225 2 payments
  2. Food and Beverage $3,936 64 payments
  3. Travel and Lodging $77 1 payment
  4. Education $35 1 payment
Products named General payments · program years 2019–2025
  1. XIAFLEX $4,596 3 payments
  2. Titan Men's Health $2,288 32 payments
  3. TITAN Penile Reconstruction $430 6 payments
  4. General - Erectile Dysfunction General - Erectile Dysfunction_URO $329 4 payments
  5. AMS 700 $299 3 payments
  6. General Therapies $269 2 payments
  7. General Erectile Dysfunction $233 3 payments
  8. AMS $178 3 payments
  9. GENERAL - ERECTILE DYSFUNCTION Erectile Dysfunction $169 2 payments
  10. AMS 700 CXR RTE KIT $102 1 payment
  11. Other $179 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Coloplast Corp $1,250 1 payment

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$224,254

Of which drugs: $134,833

Medicare patients

359

Average age 73

Services billed

4,707

31 women, 328 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 42%
Cancer 40%
Ischemic heart disease 33%
Chronic kidney disease 31%
Diabetes 26%
Atrial fibrillation 23%
Heart failure 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Bcg live intravesical instillation, 1 mg J9030 Office 19 1,150 $2,621

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record